Sei Investments Co. lessened its position in shares of Exponent, Inc. (NASDAQ:EXPO - Free Report) by 12.9% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 127,273 shares of the business services provider's stock after selling 18,900 shares during the period. Sei Investments Co. owned approximately 0.25% of Exponent worth $11,340,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds also recently made changes to their positions in EXPO. Private Trust Co. NA grew its stake in shares of Exponent by 129.8% in the fourth quarter. Private Trust Co. NA now owns 278 shares of the business services provider's stock valued at $25,000 after acquiring an additional 157 shares in the last quarter. Atala Financial Inc bought a new position in shares of Exponent during the fourth quarter worth approximately $25,000. Westside Investment Management Inc. bought a new position in shares of Exponent during the third quarter worth approximately $26,000. Tortoise Investment Management LLC raised its position in shares of Exponent by 76.7% in the fourth quarter. Tortoise Investment Management LLC now owns 440 shares of the business services provider's stock valued at $39,000 after buying an additional 191 shares in the last quarter. Finally, Trust Co. of Vermont acquired a new position in Exponent in the 4th quarter valued at $45,000. Institutional investors and hedge funds own 92.37% of the company's stock.
Insider Activity at Exponent
In other Exponent news, VP Richard Reiss sold 1,736 shares of the company's stock in a transaction that occurred on Wednesday, February 26th. The shares were sold at an average price of $85.93, for a total value of $149,174.48. Following the completion of the transaction, the vice president now directly owns 1,800 shares in the company, valued at approximately $154,674. This represents a 49.10 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. 2.10% of the stock is owned by company insiders.
Exponent Stock Performance
Shares of NASDAQ EXPO traded down $3.23 during mid-day trading on Thursday, reaching $78.52. The company had a trading volume of 280,187 shares, compared to its average volume of 233,803. The business's 50-day simple moving average is $85.79 and its 200 day simple moving average is $95.06. The firm has a market cap of $3.99 billion, a price-to-earnings ratio of 37.04 and a beta of 0.77. Exponent, Inc. has a one year low of $77.30 and a one year high of $115.75.
Exponent (NASDAQ:EXPO - Get Free Report) last announced its quarterly earnings results on Thursday, February 6th. The business services provider reported $0.46 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.40 by $0.06. Exponent had a net margin of 19.52% and a return on equity of 27.27%. During the same quarter in the prior year, the firm earned $0.41 earnings per share. On average, sell-side analysts anticipate that Exponent, Inc. will post 1.98 EPS for the current year.
Exponent Company Profile
(
Free Report)
Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.
See Also

Before you consider Exponent, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exponent wasn't on the list.
While Exponent currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.